GranuFlo® and NaturaLyte®

Free Case Evaluation

You must read the following notice before sending an e-mail message to Robins Kaplan LLP.

Any information that you send us in an e-mail message should not be confidential or otherwise privileged information. Sending us an e-mail message will not make you a client of Robins Kaplan LLP. We do not accept representation until we have had an opportunity to evaluate your matter, including but not limited to an ethical evaluation of whether we are in a conflict position to represent you. Accordingly, the information you provide to us in an e-mail should not be information for which you would have an expectation of confidentiality.

If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.

By accepting these terms, you are confirming that you have read and understood this important notice.

Thank you, your message has been sent. Please allow 24 hours for a response.

August 17, 2012

GranuFlo® and NaturaLyte® are dialysates used during kidney dialysis to remove wastes from the blood of patients with acute or chronic renal failure.  The use of GranuFlo® and NaturaLyte® has been reported in some cases to lead to a blood condition called "alkalosis," which can lead to low blood pressure and even cardiac arrest1

On May 25, 2012, the United States Food and Drug Administration (FDA) released a Safety Communication instructing health care providers to be aware of fact that GranuFlo® and NaturaLyte® can deliver an excessive amount of bicarbonate into a patient's bloodstream2

On June 27, 2012, the FDA issued a Class 1 recall of GranuFlo® and NaturaLyte®.  A Class 1 recall is used when there is a reasonable probability the product will cause serious health consequences or death3

Robins Kaplan LLP is investigating cases involving GranuFlo® and NaturaLyte®.  If you or someone you know has suffered serious injury following hemodialysis with GranuFlo® or NaturaLyte® dialysate and you wish to consult with a lawyer, please call 1.800.553.9910 or contact us.

Back to Top